Translating academic practices into a community oncology setting requires meaningful adaptations to successfully integrate practices like adoptive cell therapy, CAR-T therapies, or TCR-T therapies, ...
The combination of decitabine (DAC) and cytarabine, acclarithromycin, and granulocyte colony-stimulating factor (CAG) vs CAG alone showed greater efficacy among older patients with acute myeloid ...
The Gulliver-Gestalt-Psoriasis Area Severity Estimate (G2-PASE) was developed to address a longstanding challenge in ...
Sarah M. Lima, PhD, MPH, is an epidemiologist and postdoctoral fellow in cancer population at the Georgetown Lombardi ...
Nicholas Richardson, DO, at Precision for Medicine, breaks down minimal residual disease and MRD negativity as FDA end points ...
New KDIGO updates push earlier IgA nephropathy treatment, targeting immune pathways and nephron protection to cut proteinuria and slow eGFR decline. In this episode, Integrating Risk Stratification ...
The trial’s primary end point was overall response rate (ORR). At the 3-year mark, the ORR was 59%, with a CR rate of 41%; both rates were maintained from prior analyses, “demonstrating the stability ...
Karlitz is the senior medical officer of screening at Exact Sciences and holds a voluntary teaching position in the gastrointestinal division at the University of Colorado School of Medicine. He ...
Accessibility remains one of the largest barriers to translating academic best practices into a community oncology setting, according to several panelists at the Boston Regional Institute for ...
The 2026 International Stroke Conference (ISC), held February 4-6 in New Orleans, Louisiana, delivered potentially ...
Biagio Ricciuti, MD, discusses how access challenges and toxicity concerns slow the rollout of new T-cell engager therapies from academic centers into community oncology.
New stroke breakthroughs spotlight faster treatment, factor XI prevention, better recovery, and the push to deliver care equitably with smart wearables. Rising stroke rates in young adults highlight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results